Medindia

X

Regeneron Announces Presentation at the Cowen and Company 30th Annual Healthcare Conference

Friday, March 5, 2010 General News J E 4
Advertisement


TARRYTOWN, N.Y., March 4 Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast its presentation at the Cowen and Company 30th Annual Healthcare Conference on Tuesday, March 9, 2010. The presentation is scheduled for 11:05 a.m. Eastern Time. The session may be accessed through the Company's web site, www.regeneron.com, on the Investor Relations page. An archived version of the presentation will be available after the live webcast through April 8, 2010. Additional information about Regeneron and recent news releases are available on the Regeneron web site.

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in Phase 3 clinical trials for the potential treatment of gout, age-related macular degeneration, and certain cancers. Additional therapeutic candidates are in earlier stage development programs in rheumatoid arthritis and other inflammatory conditions, pain, cholesterol reduction, allergic conditions, and cancer. Additional information about Regeneron and recent news releases are available on Regeneron's web site at www.regeneron.com

Contact Information: Peter Dworkin Laura Lindsay Investor Relations Media Relations 914.345.7640 914.345.7800 peter.dworkin@regeneron.com laura.lindsay@regeneron.com

SOURCE Regeneron Pharmaceuticals, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Steaz(R) Plants the 'SEEDs' of Its Own Philanthrop...
S
Thyroid Disease: The Hidden Epidemic